Skip to main content
Premium Trial:

Request an Annual Quote

Peter Schultz Leaves Genomic Institute of the Novartis Research Foundation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Peter Schultz has departed as director of the Genomic Institute of the Novartis Research Foundation in San Diego, a position he has held since he founded the institute in 1999.

Schultz disclosed the departure in a revision to his biography on the website of The Scripps Research Institute, where he holds a faculty position as Scripps Family Chair Professor of Chemistry and heads a laboratory focused on the synthesis of molecules and molecular assemblies with novel physical, chemical, or biological properties and functions. The revision to his biography was first reported publicly earlier today by Xconomy San Diego.

Neither Schultz nor a Novartis spokesperson responded to e-mail and telephone messages seeking additional information.

"Given nature's "synthetic" prowess, we have undertaken a biologically inspired approach to synthesis in which the molecules and processes of living organisms are combined with the principles and tools of chemistry to create molecules with new functions difficult to generate by either approach alone," according to an overview of the research included in the website of Schultz's lab at Scripps. "By studying the properties of the resulting molecules, new insights are gained into the molecular mechanisms of complex biological and chemical systems."

According to his bio, Schultz is a founder of Affymax Research Institute, Syrrx, Kalypsys, Phenomix, Symyx Therapeutics, Ilypsa, Ambrx and Wildcat Technologies, eight life sciences companies that according to Schultz were pioneers in the application of diversity based approaches to problems in chemistry, materials science and medicine.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.